PNC Financial Services Group’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,000
Closed -$8K 4365
2021
Q2
$8K Buy
+1,000
New +$7.55K ﹤0.01% 3766
2017
Q4
Hold
0
4201
2017
Q3
Hold
0
4191
2017
Q2
Hold
0
4197
2017
Q1
Hold
0
4164
2016
Q4
Hold
0
4050
2016
Q3
Hold
0
4146
2016
Q2
Hold
0
4530
2016
Q1
Hold
0
4534
2015
Q4
Hold
0
4523
2015
Q3
Hold
0
4662
2015
Q2
Hold
0
4734
2015
Q1
Sell
-1
Closed -$1.79K 4730
2014
Q4
$1K Hold
1
﹤0.01% 3997
2014
Q3
$1K Sell
1
-6
-86% -$15.8K ﹤0.01% 3840
2014
Q2
$22K Sell
7
-18
-72% -$41.5K ﹤0.01% 2897
2014
Q1
$55K Buy
25
+19
+317% +$45.4K ﹤0.01% 2471
2013
Q4
$12K Hold
6
﹤0.01% 2941
2013
Q3
$17K Buy
+6
New +$16.3K ﹤0.01% 2936
2013
Q2
Hold
0
3455

Other funds holding MBOT

PNC Financial Services Group's MBOT Position: Q3 2021 in Review

PNC Financial Services Group sold out of Microbot Medical (MBOT) in Q3 2021, closing a stake of 1,000 shares — an estimated $8K sold.

PNC Financial Services Group first reported a position in MBOT in Q3 2013 and held it in 7 quarters. The position peaked at $55K in Q1 2014. 26 funds tracked by Wall St. Rank hold MBOT as of Q3 2021.

  • PNC Financial Services Group reported no remaining Microbot Medical position as of Q3 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 1,000 Microbot Medical shares in Q3 2021, an estimated $8K.
  • PNC Financial Services Group first reported a position in Microbot Medical in Q3 2013 and held it in 7 quarters.
  • PNC Financial Services Group's Microbot Medical position peaked at $55K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2021.

Based on PNC Financial Services Group's 13F filing for Q3 2021, filed 5 Nov 2021.